HCP Live November 25, 2024
Key Takeaways
- The ULTrA index may improve gout management by reducing hospital admissions and healthcare costs.
- Gout is often sub-optimally managed, leading to frequent flares and increased healthcare utilization.
- The study analyzed data from Singapore’s National University Health System, including 12,314 patients in 2022 and 12,789 in 2023.
- The ULTrA index was inversely associated with hospitalizations, indicating its potential utility in clinical practice.
- Further research is needed to assess the impact of real-time ULTrA visualization on prescriber behavior and hospitalization rates.
The Urate-Lowering Therapy to Acute Treatment Ratio (ULTrA) was linked to fewer gout-related hospital admissions.
New research is calling attention to the potential utility of a novel quality index, the Urate-Lowering Therapy (ULT) to Acute Treatment Ratio...